Can a supplement duo boost fertility in women with PCOS?

NCT ID NCT07266259

Recruiting now Disease control Sponsor: Mst.Sumyara Khatun Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether taking levocarnitine together with myoinositol works better than myoinositol alone for improving insulin resistance and hormone levels in women with PCOS who have trouble getting pregnant. 72 women aged 18-40 with insulin-resistant PCOS will take either the combination or myoinositol alone for 3 months. Researchers will measure changes in insulin resistance and hormone levels to see if the combo offers extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Levocarnitine and myoinositol (dietary supplements)
What this could lead to: If it works, this could point toward a better supplement combination for managing insulin resistance and hormone levels in women with PCOS who have trouble getting pregnant.
What could go wrong: This is a small, early-stage trial with only 72 participants and no blinding, so results may not be reliable or apply to everyone. The supplements may not work better than myoinositol alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME (PCOS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POLYCYSTIC OVARY SYNDROME (PCOS)

Contacts and locations

Locations

Bangladesh Medical University
NOT_YET_RECRUITING

Dhaka, Shahbag, 1000, Bangladesh
Bangladesh Medical University
RECRUITING

Dhaka, Shahbag, 1000, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.